Skip to main content

Advertisement

Log in

Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Matrix metalloproteinase-21 (MMP-21) has been shown to enhance tumor invasion and metastasis ability in some solid tumors. In the present study, we investigated the expression of MMP-21 as well as its association with overall survival of gastric cancer patients. MMP-21 expression was investigated in 296 cases of gastric cancer by immunohistochemistry assay. Statistical analysis was utilized to evaluate the association of MMP-21 expression with overall survival of patients. MMP-21 expression was proved to be increased in gastric cancer compared with that in normal tissues (P < 0.05). It was also proved MMP-21 expression was associated with tumor invasion, metastasis and TNM stage (P < 0.001). MMP-21 expression was showed to be associated with overall survival of gastric cancer patients for patients with tumor of higher MMP-21 expression tend to have worse overall survival (P < 0.001). Multivariate analysis proved MMP-21 to be an independent prognostic factor for overall survival of gastric cancer patients (P < 0.001). These results suggested the potential role of MMP-21 in progression of human gastric cancer. It might also be a novel molecular marker to predict overall survival of patients with gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  3. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17–20.

    PubMed  Google Scholar 

  4. Parsons SL, Watson SA, Brown PD, et al. Matrix metalloproteinases. Br J Surg. 1997;84:160–6.

    Article  PubMed  CAS  Google Scholar 

  5. Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000;36:1621–30.

    Article  PubMed  CAS  Google Scholar 

  6. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;30(274):21491–4.

    Article  Google Scholar 

  7. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135–49.

    PubMed  CAS  Google Scholar 

  8. Park HI, Ni J, Gerkema FE, et al. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000;275:20540–4.

    Article  PubMed  CAS  Google Scholar 

  9. Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am. 2001;10:383–92.

    PubMed  CAS  Google Scholar 

  10. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93:178–93.

    Article  PubMed  CAS  Google Scholar 

  11. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300–8.

    Article  PubMed  CAS  Google Scholar 

  12. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997;89:1260–70.

    Article  PubMed  CAS  Google Scholar 

  13. Reis ST, Leite KR, Piovesan LF, et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol. 2012;12:18.

    Article  PubMed  CAS  Google Scholar 

  14. Song N, Sung H, Choi JY, et al. Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women. Cancer Epidemiol Biomarkers Prev. 2012 Jun 5.

  15. Ng KT, Qi X, Kong KL, et al. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur J Cancer. 2011;47:2299–305.

    Article  PubMed  CAS  Google Scholar 

  16. Chen R, Cui J, Xu C, et al. The Significance of MMP-9 Over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection. Ann Surg Oncol. 2011 Jun 17.

  17. Barresi V, Vitarelli E, Tuccari G, et al. MMP-9 expression in meningiomas: a prognostic marker for recurrence risk? J Neurooncol. 2011;102:189–96.

    Article  PubMed  CAS  Google Scholar 

  18. Chen T, Zhu J. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma. Med Oncol. 2010;27:1185–91.

    Article  PubMed  CAS  Google Scholar 

  19. Zeng ZS, Huang Y, Cohen AM, et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol. 1996;14:3133–40.

    PubMed  CAS  Google Scholar 

  20. Fujimoto D, Hirono Y, Goi T, et al. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer. Anticancer Res. 2008;28:847–54.

    PubMed  CAS  Google Scholar 

  21. Partyka R, Gonciarz M, Jałowiecki P, et al. VEGF and metalloproteinase 2 (MMP-2) expression in gastric cancer tissue. Med Sci Monit. 2012; 18: BR130–4.

    Google Scholar 

  22. Noh S, Jung JJ, Jung M, et al. MMP-2 as a putative biomarker for carcinomatosis in gastric cancer. Hepatogastroenterology. 2011;58:2015–9.

    Article  PubMed  CAS  Google Scholar 

  23. Koskensalo S, Mrena J, Wiksten JP, et al. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31:149–55.

    Article  PubMed  CAS  Google Scholar 

  24. Al-Batran SE, Pauligk C, Wirtz R, et al. The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer. Ann Oncol. 2011 Nov 23.

  25. Yan D, Dai H, Liu JW. Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. BMC Cancer. 2011;11:151.

    Article  PubMed  Google Scholar 

  26. Suomela S, Koljonen V, Skoog T, et al. Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in merkel cell carcinoma. Virchows Arch. 2009;455:495–503.

    Article  PubMed  CAS  Google Scholar 

  27. Boyd S, Virolainen S, Pärssinen J, et al. MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer. Exp Dermatol. 2009;18:1044–52.

    Article  PubMed  CAS  Google Scholar 

  28. Germani RM, Civantos FJ, Elgart G, et al. Molecular markers of micrometastasis in oral cavity carcinomas. Otolaryngol Head Neck Surg. 2009;141:52–8.

    Article  PubMed  Google Scholar 

  29. Qiu W, Zhou G, Zhai Y, et al. No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2008;17:2514–8.

    Article  PubMed  CAS  Google Scholar 

  30. Bister V, Skoog T, Virolainen S, et al. Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma. Mod Pathol. 2007;20:1128–40.

    Article  PubMed  CAS  Google Scholar 

  31. Shagisultanova EI, Novikova IA, Sidorenko YS, et al. The matrix metalloproteinase-21 gene 572C/T polymorphism and the risk of breast cancer. Anticancer Res. 2004;24:199–201.

    PubMed  CAS  Google Scholar 

  32. Ahokas K, Lohi J, Illman SA, et al. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes. Lab Invest. 2003;83:1887–99.

    Article  PubMed  CAS  Google Scholar 

  33. Wu T, Li Y, Liu X, et al. Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression. J Surg Oncol. 2011;104:787–91.

    Article  PubMed  CAS  Google Scholar 

  34. Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol. 2000;53:125–30.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

We declared no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xianli He or Xilin Du.

Additional information

Tao Wu and Yi Li contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, T., Li, Y., Lu, J. et al. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer. Med Oncol 30, 323 (2013). https://doi.org/10.1007/s12032-012-0323-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-012-0323-8

Keywords

Navigation